68Ga-NK224 PET Imaging of PD-L1 Expression in Cancers

Abroad (travel likely)Recruiting

Conditions

Tumor · PD-L1

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Xiamen University, Xiamen, Fujian, China
Contact: Study coordinator (Liang Zhao) · wzhaoliang01@163.com · 86 0592-213-7366

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

PIK3CA Mutation · HER2- Negative Breast Cancer · Hormone Receptor Positive Tumor

Abroad (travel likely)RecruitingPHASE3

Gilbert, United States · Beverly Hills, United States

Study of ZGGS34 in Participants With Advanced Solid Tumors

Solid Tumor

Abroad (travel likely)RecruitingPHASE1, PHASE2

Zhengzhou, China

A Phase Ib/II Clinical Study to Evaluate HLX43 in Combination With Serplulimab in Patients With Advanced/Metastatic Solid Tumors

Solid Tumor Cancer · Non Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Hunan, China · Jinan, China

99mTc-CNDG SPECT/CT in Brain Tumors

Intracranial Tumor

Abroad (travel likely)Recruiting

Beijing, China